SBI Securities’s AbbVie ABBV Stock Holding History

SBI Securities’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.4M	Sell	61,053 -3,102	-5%	-$667K	0.35%	55
2026 Q1	$13.8M	Buy	64,155 +2,818	+5%	+$625K	0.38%	53
2025 Q4	$14M	Sell	61,337 -844	-1%	-$192K	0.36%	52
2025 Q3	$14.4M	Sell	62,181 -1,883	-3%	-$383K	0.37%	47
2025 Q2	$11.9M	Buy	64,064 +1,063	+2%	+$198K	0.34%	56
2025 Q1	$13.2M	Sell	63,001 -69	-0.1%	-$13.4K	0.44%	46
2024 Q4	$11.2M	Buy	+63,070	New	+$11.6M	0.35%	52

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SBI Securities's ABBV Position: Q2 2026 in Review

SBI Securities reduced its AbbVie (ABBV) stake by 4.8% in Q2 2026, selling an estimated $667K and leaving 61,053 shares worth $15.4M. The position accounts for 0.35% of the portfolio, ranked #55.

SBI Securities first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

SBI Securities held 61,053 shares of AbbVie worth $15.4M as of Q2 2026.
SBI Securities sold 3,102 AbbVie shares in Q2 2026, an estimated $667K.
AbbVie made up 0.35% of SBI Securities's portfolio in Q2 2026, its #55 holding.
SBI Securities first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.